T o test the hypothesis that fetal lung maturation can be accelerated by one of the xanthine derivatives, aminophyllin was given to 40 pregnant rabhits beginning on the 20th gestational day for a period of 7-10 days. The fetuses were delivered by cesarean section and fetal lung maturity was assessed by determining the biochemical. functional, and ultrastructural characteristics of aminophyllin-treated vs. control animals. The phospholipid content of the lung tissue homogenate from the aminophyllin-treated group was significantly higher than in the control subjects (saline injected) at 28 days of gestation (421 The data show that aminophyllin has accelerating effects on fetal lung maturation in rabhits when the drug is given to pregnant rabhits during the last 7-10 days of gestation.
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Speculation
Our data do not permit extrapolation into the clinical application of utilizing xanthine derivatives for the enhancement of fetal lung maturation. However. they provide evidence that there may be several pharmacologic agents that might enhance fetal lung maturation by various mechanisms. These data may also provide impetus for some centers to review the statistical correlation of respiratory distress syndrome in infants born to mothers who have received xanthine derivatives during the latter part of pregnancy for the treatment of such conditions as hronchiai asthma. if the latter clinical evidence is a positive one, it may be justified to initiate a clinical trial to evaluate the effect of xanthine derivative treatment of the mother for the purpose of preventing respiratory distress syndrome in the newborn infant.
It has been shown previously that maternal administration of steroids can induce fetal lung maturation in a number of animal species (3. 5 7. 9. 14) . Studies by Liggins and Howie (8) have demonstrated an acceleration of fetal lung maturation in humans as indicated by a reduction in the incidence of respiratory distress syndrome when a corticosteroid (bet~~methasone) was administered parentcrally to the mothers 48 72 hr before delivery. The precise mechanism by which the acceleration of fetal maturation occurs is not yet certain. Lung surfactant synthesis in the type I I cell, storage in lamellar bodies within this cell, and ultimate release into the alveolus are probably governed by a number of interrelated factors. However, recent evidence suggests that adenosine 3',5'-monophosphate (cyclic A M P ) may be one of the important intermediate compounds regulating the synthesis of surfactant (2. 13) . It is also known that drugs such as xanthine derivatives may increase the level of cyclic A M P by the inhibition of phosphodiesterase, the enzyme responsible for the normal breakdown of cyclic AMP. This study was undertaken to evaluate the effect of a xanthine derivative (aminophyllin) on the process of lung maturation in the rabbit fetus when administered to pregnant rabbits 7 10 days before term, with assessment of the rate of lung maturation by biochemical, functional, and ultrastructural measurements.
MATERIALS A N D M E T H O D S
Forty time-dated (time of mounting used as time zero) pregnant new Zealand rabbit does were treated at 20 days of gestation with twice daily intramuscular injections of either normal saline (0.5 ml/dose-control group) or aminophyllin (10 mg/kg body wt) until the time of delivery. The duration of treatment ranged from 7-10 days depending on the gestational age at the time of delivery. Thus, fetuses delivered at 27 days of gestation would have received 7 days of either normal saline or aminophyllin treatment. Those delivered at 28 days would have received 8 days. etc. The does in both treated and control groups were fed ad libitum with water and Purina chow. During the treatment period. no obvious differences were observed in activities and behaviors between the saline-and aminophyllin-trealed groups. The mean maternal weight gain during the treatment periods (initiation of saline or aminophyllin treatment to the time of delivery) was also comparable between the two groups (400 (saline) vs. 450 g (aminophyllin)).
The fetuses were delivered by hysterotomy under intravenous Nembutal anesthesia at 27, 28, 29, and 30 days of gestation. There was a 10-15% abortion rate in the treatment group. The amount of fetal wastage per litter was the same for both control and treatment groups. The fetuses were permitted to breathe room air for 15-20 min before each fetus was weighed and trucheostomy performed on one-half of the litter. There was no difference in the amount of gasping during the 15-20-min period between the treatment and control groups. After the placement of a tracheal cannula, the head and trunk below the diaphragm were removed. leaving the lungs intact within the thoracic cavity. The lung preparation was suspended in a sealed glass chamber and by using . . the microspirometer technique. 9-19 successive pressure volume curves were performed until a stable tracing was obtained (lo). The compliance for each curve (ml/cm H,O) was calculated from a stable curve using opening pressure as the reference point for the determination of tidal volume. If a lung failed to expand. as was rrequently the case in the 27-day control group. zero compliance was assigned to that lung.
After the completion of the pressure volume curves, alveolar wash was obtained from these lungs by lavaging the tracheobroncheal tree through the catheter 10-12 times with a total volume of 1 2 ml normal saline. The lungs were dried in a desiccator a t 75" for a t least 24 hr, and a dry lung weight was obtained for unit expression of phospholipid content. The alveolar washings were combined from each pair of fetal lungs, and differentially centrifuged as previously described by Redding er al. (10, I I) to obtain the surfactant pellet. The pellet was dissolved in a 2: 1 chloroforrnmethanol mixture and subsequently analyred for phospholipid content according to the method of Chen et al. (4) .
The lung tissue from the other half of the litter (three to four fetuses) was removed in toto, weighed, and homogenized in a Teflon grinder. Neutral phospholipids were isolated from other lipids using DEAE-cellulose acetate column chromatography (12) . The lung phospholipid content was expressed per unit wet weight.
The lungs from three to four fetuses belonging to the 28th to the 30th day of gestation of each group were prepared for electron microscopy using the conventional techniques. Twenty-five type 11 cells from each lung were examined and the average number of the lamellar bodies were determined by one of us (W.J.D.) who was unaware of the group source of the lung tissue.
The comparison of the data between control and arninophyllin treated groups was made by student t-test, using the means of litters.
R E S U L T S
As shown on Table I , there was no significant difference in the body weight. fresh and dry lung weights between the controls and aminophyllin-treated groups. Table 2 shows that the phospholipid content of lung tissue and alveolar wash of both control and aminophyllin-treated groups rose as would be expected with advancing gestational age. Furthermore, the arninophyllin-treated pups had significantly greater amounts of phospholipid in the lung tissue at 28 and 29 days and in the alveolar wash at 30 days. Table  3 shows that the lung compliance of both and control and arninophyllin-treated groups increased significantly with increasing gestational age. Furthermore, the lung compliance of the arninophyllin-treated pups was significantly greater than that of the controls at 27 and 28 days of gestation.
There was no significant difference in the number of lamellar bodies in the aminophyllin-treated pups at all gestational ages when compared with controls (Table 4) .
DISCUSSION
Previous reports 'nave shown that the phospholipid content of the alveolar fluid in lung tissue correlates well with functional maturation of the lung, and is a reflection of the surfactant lipids at the alveolar interface. In this study, we have shown that there is progressive increment in the phospholipid content of lung tissue and alveolar wash with increasing maturation. With maternal treatment of aminophyllin, a significantly higher phospholipid content in the lung tissue at 28 and 29 days of gestation and in the lung wash at 30 days of gestation was observed, indicating an acceleration of the rate of lung maturation in the fetus with increased synthesis, storage. and release of surfactant in the alveolar cell.
The lung compliance data provides additional support io the biochemical observations. The aniinophyllin-treated group shows greater lung compliance, which would reflect a more elastic lung as a result of a greater amount of surfuctant present at the alveolar interface. It is important to note that the improvement in lung compliance in the preterm treatment group is not better than that found in term animals. suggesting that higher levels of surfactant will not improve the mechanical property of the lung beyond its normal functional ability at term.
Other studies have suggested that the lamellar bodies are the site of surfactant production and release and. therefore, their appear- ance should correlate with the biochemical and functional status of the lung (1, 15) . We were unable to show an absolute increase in the number of lamellar bodies in the aminophyllin-treated group.
It is possible that aminophyllin. acting as a phosphodiesterase inhibitor, would increase the quantity of cyclic A M P available in the lamellar body, which in turn would produce more surfactant. If this is true, it may not be necessary for the increment in functional activity to be accompanied by an increase in the number of lamellar bodies in the type 11 cell.
A recent study by Barrett et al. (2) demonstrated that pregnant rabbits treated with aminophyllin showed an increase in cyclic A M P in the lung tissue of the fetus. This would further support the theory that the mechanism of the stimulatory effect of aminophyllin on fetal lung maturation is mediated through increased levels of cyclic A M P in the lung tissue secondary to the inhibition of phosphodiesterase.
S U M M A R Y
Maternal administration of aminophyllin produced a biochemical and functional enhancement of the rabbit fctal pulmonary maturation. Greater amounts of phospholipid were found in the lung tissue homogenate of fetuses at 28 and 29 days of gestation, and the phospholipid content of the alveolar wash was also higher at 30 days in the sminophyllin-treated fetuses. Lung coniplinnce was higher in the experimental animals ;it 27 and ZX days of gestation. N o difference was obscrved in the number of lamellar bodies in the type I I cell between the aminophyllin-treated and the control group. It was hypothesized that aminophyllin enhanced fetal lung maturation by inhibiting the phosphodiesterase activity (enzyme responsible for the degradation of cyclic A M P ) , hence resulting in a higher concentration of cyclic A M P , a known essential intermediary substance for the synthesis of surfactant in 
